Literature DB >> 28830907

Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction.

Francesca Zimetti1, Stefano De Vuono2, Monica Gomaraschi3, Maria Pia Adorni4, Elda Favari4, Nicoletta Ronda4, Maria Anastasia Ricci2, Fabrizio Veglia5, Laura Calabresi3, Graziana Lupattelli2.   

Abstract

Acute phase reaction (APR) is a systemic inflammation triggered by several conditions associated with lipid profile alterations. We evaluated whether APR also associates with changes in cholesterol synthesis and absorption, HDL structure, composition, and cholesterol efflux capacity (CEC). We analyzed 59 subjects with APR related to infections, oncologic causes, or autoimmune diseases and 39 controls. We detected no difference in markers of cholesterol synthesis and absorption. Conversely, a significant reduction of LpA-I- and LpAI:AII-containing HDL (-28% and -44.8%, respectively) and of medium-sized HDL (-10.5%) occurred in APR. Total HDL CEC was impaired in APR subjects (-18%). Evaluating specific CEC pathways, we found significant reductions in CEC by aqueous diffusion and by the transporters scavenger receptor B-I and ABCG1 (-25.5, -41.1 and -30.4%, respectively). ABCA1-mediated CEC was not affected. Analyses adjusted for age and gender provided similar results. In addition, correcting for HDL-cholesterol (HDL-C) levels, the differences in aqueous diffusion total and ABCG1-CEC remained significant. APR subjects displayed higher levels of HDL serum amyloid A (+20-folds; P = 0.003). In conclusion, APR does not associate with cholesterol synthesis and absorption changes but with alterations of HDL composition and a marked impairment of HDL CEC, partly independent of HDL-C serum level reduction.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  HDL structure; campesterol; cholesterol absorption; cholesterol biosynthesis; cholesterol efflux; inflammation; lathosterol; lipoproteins; serum amyloid A; sitosterol

Mesh:

Substances:

Year:  2017        PMID: 28830907      PMCID: PMC5625127          DOI: 10.1194/jlr.P076463

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  63 in total

1.  Cardiovascular disease. Does inflammation cut to the heart of the matter?

Authors:  Gary Taubes
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

2.  Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome.

Authors:  Monica Gomaraschi; Alice Ossoli; Elda Favari; Maria Pia Adorni; Gianfranco Sinagra; Luigi Cattin; Fabrizio Veglia; Franco Bernini; Guido Franceschini; Laura Calabresi
Journal:  Cardiovasc Res       Date:  2013-06-28       Impact factor: 10.787

Review 3.  High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis.

Authors:  Wijtske Annema; Arnold von Eckardstein
Journal:  Circ J       Date:  2013-09-20       Impact factor: 2.993

Review 4.  The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption.

Authors:  T A Miettinen; H Gylling; M J Nissinen
Journal:  Nutr Metab Cardiovasc Dis       Date:  2011-09-07       Impact factor: 4.222

Review 5.  The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality.

Authors:  Nicole Prüfer; Burkhard Kleuser; Markus van der Giet
Journal:  Biol Chem       Date:  2015-06       Impact factor: 3.915

Review 6.  Effect of inflammatory mediators on cardiovascular function.

Authors:  Ursula Müller-Werdan; Roland Prondzinsky; Karl Werdan
Journal:  Curr Opin Crit Care       Date:  2016-10       Impact factor: 3.687

7.  Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism.

Authors:  Nicoletta Ronda; Daniela Greco; Maria Pia Adorni; Francesca Zimetti; Elda Favari; Gunnbjørg Hjeltnes; Knut Mikkelsen; Maria Orietta Borghi; Ennio Giulio Favalli; Rita Gatti; Ivana Hollan; Pier Luigi Meroni; Franco Bernini
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

8.  Psoriasis alters HDL composition and cholesterol efflux capacity.

Authors:  Michael Holzer; Peter Wolf; Sanja Curcic; Ruth Birner-Gruenberger; Wolfgang Weger; Martin Inzinger; Dalia El-Gamal; Christian Wadsack; Akos Heinemann; Gunther Marsche
Journal:  J Lipid Res       Date:  2012-05-30       Impact factor: 5.922

9.  HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis.

Authors:  Preethi Mani; Kiyoko Uno; MyNgan Duong; Kathy Wolski; Steven Spalding; M Elaine Husni; Stephen J Nicholls
Journal:  Cardiovasc Diagn Ther       Date:  2016-02

Review 10.  High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.

Authors:  Wolfgang Koenig
Journal:  Int J Cardiol       Date:  2013-08-24       Impact factor: 4.164

View more
  12 in total

1.  ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease.

Authors:  Cinzia Marchi; Maria Pia Adorni; Paolo Caffarra; Nicoletta Ronda; Marco Spallazzi; Federica Barocco; Daniela Galimberti; Franco Bernini; Francesca Zimetti
Journal:  J Lipid Res       Date:  2019-06-05       Impact factor: 5.922

2.  Editorial: The Roles of Lipids in Immunometabolism: The Crosstalk Between Lipid Metabolisms and Inflammation.

Authors:  Jue Zhang; Wen Dai; Yiliang Chen
Journal:  Front Cardiovasc Med       Date:  2022-06-22

3.  Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis.

Authors:  R Kaseda; Y Tsuchida; J L Gamboa; J Zhong; L Zhang; H Yang; A Dikalova; A Bian; S Davies; A F Fogo; M F Linton; N J Brown; T A Ikizler; V Kon
Journal:  Nutr Metab Cardiovasc Dis       Date:  2018-03-08       Impact factor: 4.222

4.  HDL inflammatory index correlates with and predicts severity of organ failure in patients with sepsis and septic shock.

Authors:  Faheem W Guirgis; Sunita Dodani; Christiaan Leeuwenburgh; Lyle Moldawer; Jennifer Bowman; Colleen Kalynych; Victor Grijalva; Srinivasa T Reddy; Alan E Jones; Frederick A Moore
Journal:  PLoS One       Date:  2018-09-14       Impact factor: 3.240

5.  Attenuation of atherogenic apo B-48-dependent hyperlipidemia and high density lipoprotein remodeling induced by vitamin C and E combination and their beneficial effect on lethal ischemic heart disease in mice.

Authors:  S Contreras-Duarte; P Chen; M Andía; S Uribe; P Irarrázaval; S Kopp; S Kern; G Marsche; D Busso; C Wadsack; A Rigotti
Journal:  Biol Res       Date:  2018-09-15       Impact factor: 5.612

Review 6.  Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review.

Authors:  Francesca Zimetti; Maria Pia Adorni; Judit Marsillach; Cinzia Marchi; Alessandro Trentini; Giuseppe Valacchi; Carlo Cervellati
Journal:  Oxid Med Cell Longev       Date:  2021-01-08       Impact factor: 6.543

7.  Marked Changes in Serum Amyloid A Distribution and High-Density Lipoprotein Structure during Acute Inflammation.

Authors:  Shitsuko Shimano; Ryunosuke Ohkawa; Mayu Nambu; Mai Sasaoka; Azusa Yamazaki; Yuki Fujii; Yuna Horiuchi; Shao-Jui Lai; Takahiro Kameda; Naoya Ichimura; Koji Fujita; Shuji Tohda; Minoru Tozuka
Journal:  Biomed Res Int       Date:  2021-01-27       Impact factor: 3.411

8.  Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation.

Authors:  Marcella Palumbo; Antonina Giammanco; Francesco Purrello; Chiara Pavanello; Giuliana Mombelli; Antonino Di Pino; Salvatore Piro; Angelo Baldassare Cefalù; Laura Calabresi; Maurizio Averna; Franco Bernini; Francesca Zimetti; Maria Pia Adorni; Roberto Scicali
Journal:  Front Mol Biosci       Date:  2022-07-19

Review 9.  High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives.

Authors:  Maria Pia Adorni; Nicoletta Ronda; Franco Bernini; Francesca Zimetti
Journal:  Cells       Date:  2021-03-05       Impact factor: 7.666

10.  HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study.

Authors:  Bianca Papotti; Chiara Macchi; Chiara Favero; Simona Iodice; Maria Pia Adorni; Francesca Zimetti; Alberto Corsini; Stefano Aliberti; Francesco Blasi; Stefano Carugo; Valentina Bollati; Marco Vicenzi; Massimiliano Ruscica
Journal:  J Clin Med       Date:  2021-12-18       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.